Loading…
Gossamer Bio, Inc. is projected to rise to $0.2108 by 2027, a +24% move from its current price of $0.1697. GOSS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.1613 | $0.1697 | $0.1786 | +0.03% |
| Jul 13 | $0.158 | $0.1698 | $0.1824 | +0.06% |
| Jul 14 | $0.1555 | $0.1698 | $0.1855 | +0.08% |
| Jul 15 | $0.1535 | $0.1699 | $0.1881 | +0.11% |
| Jul 16 | $0.1517 | $0.1699 | $0.1904 | +0.14% |
| Jul 17 | $0.1501 | $0.17 | $0.1925 | +0.17% |
| Jul 18 | $0.1486 | $0.17 | $0.1945 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1486 | $0.17 | $0.1945 | +0.20% |
| Week 2 | $0.1409 | $0.1704 | $0.206 | +0.39% |
| Week 3 | $0.1352 | $0.1707 | $0.2154 | +0.59% |
| Week 4 | $0.1307 | $0.171 | $0.2238 | +0.78% |
| Week 5 | $0.1269 | $0.1714 | $0.2314 | +0.98% |
| Week 6 | $0.1235 | $0.1717 | $0.2386 | +1.18% |
| Week 7 | $0.1206 | $0.172 | $0.2455 | +1.37% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.
The company develops GB002, an inhaled, small molecule inhibitor of PDGFR, CSF1R and c-KIT, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds.
The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. It was incorporated in 2015 and is headquartered in San Diego, California.
Gossamer Bio, Inc. (GOSS) is a healthcare stock with current price $0.1775 and market cap $86.77M, ranking 4295 by market cap.
The 30-day technical picture shows neutral sentiment with RSI14 at 40. The stock trades below SMA50 of $0.2351 and far below SMA200 of $1.61, indicating near-term weakness.
Support is at $0.156 and resistance at $0.231; the 30-day range low is $0.1245 and high is $0.253. Annualized volatility stands at 100%.
A major floor 34.8% below — a decisive break under it would weaken the trend.
The nearest floor, 8.1% below — buyers have tended to step in here.
The nearest ceiling, 36.1% above — a clean break opens room to run.
A major ceiling 241.8% above — clearing it would confirm fresh momentum.
Key GOSS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GOSS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.1774 | Sell | $0.1731 | Sell |
| MA 10 | $0.1714 | Sell | $0.1728 | Sell |
| MA 20 | $0.1702 | Sell | $0.1778 | Sell |
| MA 50 | $0.2242 | Sell | $0.2693 | Sell |
| MA 100 | $0.388 | Sell | $0.6016 | Sell |
| MA 200 | $1.57 | Sell | $1.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.78 | Neutral |
| Stoch RSI (14) | 53.41 | Neutral |
| CCI (20) | -2.36 | Neutral |
| Williams %R (14) | -65.79 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -0.58 | Sell |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 34.21 | Neutral |
| TRIX (15) | -1.29 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 50.62 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 0.17 | Sell |
| ADX (14) | 24.75 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day picture shows neutral sentiment with RSI14 at 40. Price is below the SMA50 of $0.2351 and well below the SMA200 of $1.61, indicating near-term softness. Support is at $0.156 and resistance at $0.231, with a 30-day range from $0.1245 to $0.253.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.156 | $0.1697 | $0.2543 | 0% | Neutral | |
| $0.1544 | $0.2108 | $0.3108 | +24% | Bullish | |
| $0.1821 | $0.2632 | $0.4125 | +55% | Bullish | |
| $0.1842 | $0.2796 | $0.4593 | +65% | Bullish | |
| $0.1757 | $0.2787 | $0.476 | +64% | Bullish | |
| $0.1679 | $0.2776 | $0.4901 | +64% | Bullish | |
| $0.1428 | $0.2454 | $0.4464 | +45% | Bullish | |
| $0.1458 | $0.2602 | $0.486 | +53% | Bullish | |
| $0.1779 | $0.3293 | $0.6301 | +94% | Bullish | |
| $0.2071 | $0.3973 | $0.7774 | +134% | Bullish | |
| $0.1628 | $0.3617 | $0.7758 | +113% | Bullish | |
| $0.4198 | $0.9329 | $2.15 | +450% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.156 | $0.1697 | $0.1962 | +0.00% |
| August 2026 | $0.1354 | $0.1637 | $0.2058 | -3.53% |
| September 2026 | $0.1421 | $0.1741 | $0.2232 | +6.33% |
| October 2026 | $0.1379 | $0.1708 | $0.2227 | -1.87% |
| November 2026 | $0.1371 | $0.1716 | $0.2268 | +0.44% |
| December 2026 | $0.1505 | $0.19 | $0.2543 | +10.75% |
Click any year to see its month-by-month GOSS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GOSS price prediction for 2026 points to an average of $0.1697 (low $0.156, high $0.2543) — a potential gain of 0% on today's $0.1697. A consolidation phase looks the most probable path here.
In 2027, GOSS is projected to trade between $0.1544 and $0.3108, averaging $0.2108 — a potential gain of +24% from today's $0.1697. That is up +24% on the projected 2026 average. Momentum favours further upside here.
Gossamer Bio, Inc.'s 2028 outlook centres on $0.2632, within a $0.1821 to $0.4125 range. That is up +25% on the projected 2027 average. That marks a +55% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, GOSS could reach as high as $0.4593, with a base case around $0.2796 and support toward $0.1842 — roughly +65% from $0.1697. Momentum favours further upside here.
Expect GOSS to range from $0.1757 to $0.476 through 2030. The $0.2787 average target implies a +64% move from current prices. That is 0% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The GOSS price prediction for 2031 points to an average of $0.2776 (low $0.1679, high $0.4901) — a potential gain of +64% on today's $0.1697. Momentum favours further upside here.
In 2032, GOSS is projected to trade between $0.1428 and $0.4464, averaging $0.2454 — a potential gain of +45% from today's $0.1697. That is -12% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Gossamer Bio, Inc.'s 2033 outlook centres on $0.2602, within a $0.1458 to $0.486 range. That is up +6% on the projected 2032 average. That marks a +53% change versus current levels. Momentum favours further upside here.
By 2034, GOSS could reach as high as $0.6301, with a base case around $0.3293 and support toward $0.1779 — roughly +94% from $0.1697. Buyers look set to stay in control over this stretch.
Expect GOSS to range from $0.2071 to $0.7774 through 2035. The $0.3973 average target implies a +134% move from current prices. That is up +21% on the projected 2034 average. Momentum favours further upside here.
The GOSS price prediction for 2040 points to an average of $0.3617 (low $0.1628, high $0.7758) — a potential gain of +113% on today's $0.1697. Buyers look set to stay in control over this stretch.
In 2050, GOSS is projected to trade between $0.4198 and $2.15, averaging $0.9329 — a potential gain of +450% from today's $0.1697. That is up +158% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GOSS today (≈ 5,892.751915 GOSS) could be worth
$5,497.07
+$4,497.07 (+450%) by 2050 · US Dollar
Based on the average projected GOSS price of $0.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GOSSwould be worth at today's price.
$1,000 invested in GOSS on Jul 10, 2025 (≈ 735.29411 GOSS) would be worth
$124.78
-$875.22 (-87.5%) today · 0.12× · US Dollar
Based on a GOSS entry price of $1.36 vs. today's $0.1697.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.173 | $980.92 | -1.9% |
| 1 month ago | $0.156 | $1,087.82 | +8.8% |
| 3 months ago | $0.41 | $413.9 | -58.6% |
| 6 months ago | $2.52 | $67.34 | -93.3% |
| 1 year ago | $1.36 | $124.78 | -87.5% |
| All time (5.0y) ago | $7.9 | $21.48 | -97.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GOSS forecast.
Our base-case forecast reaches $0.34 around 2035.
Implied market cap at $0.34: $166.21M
2026 shows a neutral stance with avg $0.1775 and min $0.156 and max $0.2794; 2027 shifts to bullish with avg $0.2398 and ROI 35.1%. 2028 shows further upside with avg $0.3022 and ROI 70.3%; 2029 with avg $0.3215 and ROI 81.1%; 2030 with avg $0.3183 and ROI 79.3% (min $0.1967, max $0.5527). 2031 presents avg $0.3213 and ROI 81% (min $0.19, max $0.5774); 2032 shows min $0.1626, avg $0.2868, max $0.5315 with ROI 61.6%.
2033 has avg $0.3133 and ROI 76.5%; 2034 has avg $0.4184 and ROI 135.7%; 2035 has avg $0.4964 and ROI 179.7%. 2040 projects avg $0.4669 and max $1.03 with ROI 163.1%; 2050 projects avg $1.22 and max $2.80 with ROI 585.2% (min $0.5473). Bullish sentiment dominates; these are estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast lists min $0.1967, avg $0.3183, max $0.5527 with ROI 79.3% and a bullish sentiment.
Forecasts show bullish sentiment from 2027 onward with rising average prices and ROI up to 585.2% by 2050, though 2026 is neutral and these figures are estimates, not guarantees.
The 2040 forecast lists max $1.03, with avg $0.4669 and min $0.2101, so reaching $1 is possible according to the forecast but not guaranteed.
Current price $0.1775; Market cap $86.77M.
Avg $1.22; Min $0.5473; Max $2.80; ROI 585.2%; sentiment BULLISH.
Gossamer Bio, Inc. Community Discussion
0Share your Gossamer Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.